Emergence of SARS-CoV-2 B.1.1.7 Lineage at Outpatient Testing Site, Berlin, Germany, January–March 2021
Within 5 weeks in 2021, B.1.1.7 became the dominant severe acute respiratory syndrome coronavirus 2 lineage at an outpatient testing site in Berlin, Germany. Compared with outpatients with wild-type virus infection, patients with B.1.1.7 had similar cycle threshold values, more frequent sore throat...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2021-07-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/27/7/21-0845_article |
_version_ | 1818884525798719488 |
---|---|
author | Welmoed van Loon Heike Rössig Susen Burock Jörg Hofmann Julian Bernhard Elisabeth Linzbach Domenika Pettenkofer Christian Schönfeld Maximilian Gertler Joachim Seybold Tobias Kurth Frank P. Mockenhaupt |
author_facet | Welmoed van Loon Heike Rössig Susen Burock Jörg Hofmann Julian Bernhard Elisabeth Linzbach Domenika Pettenkofer Christian Schönfeld Maximilian Gertler Joachim Seybold Tobias Kurth Frank P. Mockenhaupt |
author_sort | Welmoed van Loon |
collection | DOAJ |
description | Within 5 weeks in 2021, B.1.1.7 became the dominant severe acute respiratory syndrome coronavirus 2 lineage at an outpatient testing site in Berlin, Germany. Compared with outpatients with wild-type virus infection, patients with B.1.1.7 had similar cycle threshold values, more frequent sore throat and travel history, and less frequent anosmia/ageusia. |
first_indexed | 2024-12-19T15:50:56Z |
format | Article |
id | doaj.art-306762fd74524aeeb5013b9c091da883 |
institution | Directory Open Access Journal |
issn | 1080-6040 1080-6059 |
language | English |
last_indexed | 2024-12-19T15:50:56Z |
publishDate | 2021-07-01 |
publisher | Centers for Disease Control and Prevention |
record_format | Article |
series | Emerging Infectious Diseases |
spelling | doaj.art-306762fd74524aeeb5013b9c091da8832022-12-21T20:15:12ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592021-07-012771931193410.3201/eid2707.210845Emergence of SARS-CoV-2 B.1.1.7 Lineage at Outpatient Testing Site, Berlin, Germany, January–March 2021Welmoed van LoonHeike RössigSusen BurockJörg HofmannJulian BernhardElisabeth LinzbachDomenika PettenkoferChristian SchönfeldMaximilian GertlerJoachim SeyboldTobias KurthFrank P. MockenhauptWithin 5 weeks in 2021, B.1.1.7 became the dominant severe acute respiratory syndrome coronavirus 2 lineage at an outpatient testing site in Berlin, Germany. Compared with outpatients with wild-type virus infection, patients with B.1.1.7 had similar cycle threshold values, more frequent sore throat and travel history, and less frequent anosmia/ageusia.https://wwwnc.cdc.gov/eid/article/27/7/21-0845_articleCOVID-19coronavirus diseaseSARS-CoV-2severe acute respiratory syndrome coronavirus 2virusesrespiratory infections |
spellingShingle | Welmoed van Loon Heike Rössig Susen Burock Jörg Hofmann Julian Bernhard Elisabeth Linzbach Domenika Pettenkofer Christian Schönfeld Maximilian Gertler Joachim Seybold Tobias Kurth Frank P. Mockenhaupt Emergence of SARS-CoV-2 B.1.1.7 Lineage at Outpatient Testing Site, Berlin, Germany, January–March 2021 Emerging Infectious Diseases COVID-19 coronavirus disease SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 viruses respiratory infections |
title | Emergence of SARS-CoV-2 B.1.1.7 Lineage at Outpatient Testing Site, Berlin, Germany, January–March 2021 |
title_full | Emergence of SARS-CoV-2 B.1.1.7 Lineage at Outpatient Testing Site, Berlin, Germany, January–March 2021 |
title_fullStr | Emergence of SARS-CoV-2 B.1.1.7 Lineage at Outpatient Testing Site, Berlin, Germany, January–March 2021 |
title_full_unstemmed | Emergence of SARS-CoV-2 B.1.1.7 Lineage at Outpatient Testing Site, Berlin, Germany, January–March 2021 |
title_short | Emergence of SARS-CoV-2 B.1.1.7 Lineage at Outpatient Testing Site, Berlin, Germany, January–March 2021 |
title_sort | emergence of sars cov 2 b 1 1 7 lineage at outpatient testing site berlin germany january march 2021 |
topic | COVID-19 coronavirus disease SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 viruses respiratory infections |
url | https://wwwnc.cdc.gov/eid/article/27/7/21-0845_article |
work_keys_str_mv | AT welmoedvanloon emergenceofsarscov2b117lineageatoutpatienttestingsiteberlingermanyjanuarymarch2021 AT heikerossig emergenceofsarscov2b117lineageatoutpatienttestingsiteberlingermanyjanuarymarch2021 AT susenburock emergenceofsarscov2b117lineageatoutpatienttestingsiteberlingermanyjanuarymarch2021 AT jorghofmann emergenceofsarscov2b117lineageatoutpatienttestingsiteberlingermanyjanuarymarch2021 AT julianbernhard emergenceofsarscov2b117lineageatoutpatienttestingsiteberlingermanyjanuarymarch2021 AT elisabethlinzbach emergenceofsarscov2b117lineageatoutpatienttestingsiteberlingermanyjanuarymarch2021 AT domenikapettenkofer emergenceofsarscov2b117lineageatoutpatienttestingsiteberlingermanyjanuarymarch2021 AT christianschonfeld emergenceofsarscov2b117lineageatoutpatienttestingsiteberlingermanyjanuarymarch2021 AT maximiliangertler emergenceofsarscov2b117lineageatoutpatienttestingsiteberlingermanyjanuarymarch2021 AT joachimseybold emergenceofsarscov2b117lineageatoutpatienttestingsiteberlingermanyjanuarymarch2021 AT tobiaskurth emergenceofsarscov2b117lineageatoutpatienttestingsiteberlingermanyjanuarymarch2021 AT frankpmockenhaupt emergenceofsarscov2b117lineageatoutpatienttestingsiteberlingermanyjanuarymarch2021 |